Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 50851-50900 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05166616
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
PHASE1
Recruiting
30 participants
Started: Mar 7, 2022 · Completed: Oct 28, 2027
10 conditions
2 sponsors
1 location
NCT06782802
Clinical Significance and Prognostic Value of Prenatal Diagnosis of Obliteration of the Cavum Septum Pellucidum
N/A
Recruiting
15 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04968964
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
NA
Recruiting
55 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2029
2 conditions
2 sponsors
1 location
NCT06436846
Genomic Risk in Retroperitoneal Sarcoma
N/A
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Aug 1, 2027
2 conditions
1 sponsor
1 location
NCT05985447
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
N/A
Recruiting
180 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05246345
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
N/A
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2027
5 conditions
1 sponsor
14 locations
NCT05091424
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
PHASE1
Recruiting
137 participants
Started: Mar 7, 2022 · Completed: Feb 28, 2030
1 condition
1 sponsor
30 locations
NCT04883411
CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
NA
Recruiting
50 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
6 conditions
4 sponsors
4 locations
NCT05304767
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
PHASE3
Recruiting
280 participants
Started: Mar 7, 2022 · Completed: Mar 19, 2026
1 condition
1 sponsor
175 locations
NCT05261139
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
PHASE3
Recruiting
160 participants
Started: Mar 7, 2022 · Completed: Jul 30, 2026
1 condition
1 sponsor
73 locations
NCT05046860
Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements
NA
Recruiting
43 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
4 locations
NCT05160506
Corticosteroids to Treat Pancreatitis
PHASE2
Recruiting
86 participants
Started: Mar 6, 2022 · Completed: Apr 30, 2027
4 conditions
1 sponsor
1 location
NCT05061862
Cardiac Implantable Electronic Device (CIED) Research Study
N/A
Recruiting
1,000 participants
Started: Mar 6, 2022 · Completed: May 1, 2026
3 conditions
1 sponsor
9 locations
NCT05781386
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors
PHASE1
Recruiting
255 participants
Started: Mar 6, 2022 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT05267886
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
PHASE4
Recruiting
346 participants
Started: Mar 5, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT05215340
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
PHASE3
Recruiting
740 participants
Started: Mar 4, 2022 · Completed: Apr 30, 2028
1 condition
3 sponsors
242 locations
NCT05336084
Circadian Rhythms and Homeostatic Sleep Drive and Their Effect on Reward and Cognitive Control Systems in Adolescents
NA
Recruiting
96 participants
Started: Mar 4, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05424393
Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients
N/A
Recruiting
500 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05304962
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
PHASE1
Recruiting
64 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
8 locations
NCT04468360
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
PHASE2
Recruiting
256 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT04977180
Cardioprotection in AML
PHASE2
Recruiting
70 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2028
2 conditions
1 sponsor
1 location
NCT05273307
Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy
PHASE3
Recruiting
40 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
2 conditions
3 sponsors
1 location
NCT05038592
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
PHASE1/PHASE2
Recruiting
64 participants
Started: Mar 4, 2022 · Completed: Jan 29, 2026
4 conditions
1 sponsor
1 location
NCT05024981
Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident
NA
Recruiting
64 participants
Started: Mar 4, 2022 · Completed: Jan 4, 2027
1 condition
1 sponsor
1 location
NCT05714111
Radiology Registry on Pancreatic Malignancies
N/A
Recruiting
1,300 participants
Started: Mar 4, 2022 · Completed: Mar 30, 2030
4 conditions
1 sponsor
1 location
NCT05310734
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
PHASE4
Recruiting
50 participants
Started: Mar 4, 2022 · Completed: Mar 31, 2026
1 condition
6 sponsors
3 locations
NCT05240885
Metabolic and Functional Consequences of Aging in Health and Disease
N/A
Recruiting
100 participants
Started: Mar 4, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04645160
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
PHASE1/PHASE2
Recruiting
31 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06327776
New Protein Biomarkers and Technology for Improving Diagnosis and Outcome Prediction in Mild TBI
N/A
Recruiting
1,000 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05112991
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
PHASE2
Recruiting
108 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
19 locations
NCT05410028
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
N/A
Recruiting
1,000 participants
Started: Mar 3, 2022 · Completed: Mar 3, 2026
1 condition
1 sponsor
1 location
NCT05235659
EMPOWERYOU: Examining an Internet-based Prevention Program for Primary Caregivers
NA
Recruiting
317 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2024
1 condition
5 sponsors
2 locations
NCT05189860
The C-MIC-II Follow-Up Study
NA
Recruiting
31 participants
Started: Mar 3, 2022 · Completed: Nov 15, 2026
1 condition
1 sponsor
6 locations
NCT05205850
A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
PHASE1/PHASE2
Recruiting
135 participants
Started: Mar 3, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
2 locations
NCT05982912
VOC in Breath Samples for the Diagnosis of IPA
N/A
Recruiting
200 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT07131631
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
N/A
Recruiting
125 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2027
2 conditions
1 sponsor
6 locations
NCT05294042
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
NA
Recruiting
154 participants
Started: Mar 3, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05171244
Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)
NA
Recruiting
50 participants
Started: Mar 3, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
2 locations
NCT05329350
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
N/A
Recruiting
100 participants
Started: Mar 3, 2022 · Completed: Oct 1, 2029
1 condition
1 sponsor
1 location
NCT04775706
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
PHASE2
Recruiting
18 participants
Started: Mar 3, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
13 locations
NCT05109429
Developing a Clinical Outcome Assessment for Opioid Craving
NA
Recruiting
81 participants
Started: Mar 3, 2022 · Completed: Sep 30, 2026
3 conditions
2 sponsors
1 location
NCT05036226
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
PHASE1/PHASE2
Recruiting
76 participants
Started: Mar 3, 2022 · Completed: May 21, 2027
2 conditions
1 sponsor
1 location
NCT06242873
Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury
NA
Recruiting
20 participants
Started: Mar 3, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05152888
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk
PHASE4
Recruiting
50 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06143124
Bismuth Quadruple Therapy Versus Standard Triple Therapy
PHASE4
Recruiting
216 participants
Started: Mar 3, 2022 · Completed: Nov 3, 2025
1 condition
1 sponsor
1 location
NCT05805020
Cellvizio to Evaluate Margins in Crohn's Ileal Disease
NA
Recruiting
41 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
1 location
NCT05276596
Evaluation of the Early Use of Norepinephrine in Major Abdominal Surgery on Postoperative Organ Dysfunction
PHASE3
Recruiting
500 participants
Started: Mar 3, 2022 · Completed: Jul 31, 2025
4 conditions
1 sponsor
1 location
NCT05258656
Childhood Activities Nutrition and Development Oversight
NA
Recruiting
1,800 participants
Started: Mar 3, 2022 · Completed: Jun 30, 2028
1 condition
2 sponsors
2 locations
NCT05106855
Comparative Study of Immediate Single Unit Implants in Early Loading Protocols, With or Without Photobiomodulation.
NA
Recruiting
60 participants
Started: Mar 3, 2022 · Completed: Dec 20, 2024
3 conditions
1 sponsor
1 location
NCT05301608
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
PHASE1/PHASE2
Recruiting
30 participants
Started: Mar 3, 2022 · Completed: Jun 9, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
1015
1016
1017
1018
1019
1020
1021
More pages
1333
Next